Unknown

Dataset Information

0

Serratia endocarditis: antimicrobial management strategies and clinical outcomes.


ABSTRACT:

Objectives

The incidence of Serratia endocarditis is increasing, yet optimal treatment has not been defined. Our objective was to investigate the outcomes of patients with Serratia endocarditis by treatment strategy.

Methods

We reviewed adult patients with definitive Serratia endocarditis at two independent health systems between July 2001 and April 2023. Combination therapy was defined as receipt of ≥2 in vitro active agents for ≥72 h.

Results

Seventy-five patients were included; 64% (48/75) were male and 85% (64/75) were people who inject drugs. Compared with monotherapy, receipt of combination therapy was associated with lower rates of microbiological failure (0% versus 15%, P = 0.026) and 90 day all-cause mortality (11% versus 31%, P = 0.049). Antimicrobial discontinuation due to an adverse event was more common among patients receiving combination therapy compared with monotherapy (36% versus 8%, P = 0.058).

Conclusions

In the largest series of Serratia endocarditis to date, combination antibiotic treatment was associated with improved outcomes. However, larger, prospective studies are warranted.

SUBMITTER: Shah S 

PROVIDER: S-EPMC10940736 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Serratia endocarditis: antimicrobial management strategies and clinical outcomes.

Shah Sunish S   McCrary Madeline M   Schranz Asher J AJ   Clarke Lloyd L   Davis Matthew W MW   Marx Ashley A   Slain Douglas D   Stoner Bobbi Jo BJ   Topal Jeffrey J   Shields Ryan K RK  

The Journal of antimicrobial chemotherapy 20231001 10


<h4>Objectives</h4>The incidence of Serratia endocarditis is increasing, yet optimal treatment has not been defined. Our objective was to investigate the outcomes of patients with Serratia endocarditis by treatment strategy.<h4>Methods</h4>We reviewed adult patients with definitive Serratia endocarditis at two independent health systems between July 2001 and April 2023. Combination therapy was defined as receipt of ≥2 in vitro active agents for ≥72 h.<h4>Results</h4>Seventy-five patients were in  ...[more]

Similar Datasets

| S-EPMC12789728 | biostudies-literature
| S-EPMC10339155 | biostudies-literature
| S-EPMC1861013 | biostudies-literature